The GAPP Study is a multicentre, non-profit Phase III clinical trial sponsored by TEDDY Network to evaluate the efficacy, safety, and pharmacokinetics of a paediatric liquid formulation of gabapentin for chronic moderate to severe neuropathic, nociplastic, or mixed...
Patient Advisory Board Begins Active Contribution to the GAPP Study
The GAPP Patient Advisory Board Held Its Inaugural Meeting to Review the Study Protocol Following the recent announcement of the establishment of the Patient Advisory Board (PAB) for the GAPP Study (Gabapentin in Paediatric Pain), TEDDY is pleased to share that the...
Expression of interest to join the Patient Advisory Board (PAB)— Gabapentin in Paediatric Chronic Pain study (GAPP Study)
Are you a child or an adolescent, or do you care for someone, living with moderate to severe chronic pain? Would you be interested in joining a Patient Advisory Board (PAB) to contribute directly to research, engage with experts, and take part in decision-making...